PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

NCT05468138 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

141

Enrollment

OTHER

Sponsor class

Conditions

MSI-H
PD-1 Immunotherapy
Gastric Cancer
Adjuvant Therapy

Interventions

DRUG: SOX
DRUG: XELOX
OTHER: Observation
DRUG: PD-1 antibody

Sponsor

Fudan University